Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Busulfan × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 9 Myelodysplastic Syndromes 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Myeloproliferative Disorders 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphoid 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 Primary Myelofibrosis 1 Preleukemia 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Neuroblastoma 1 Neoplasms by Histologic Type 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lymphatic Diseases 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Immunoproliferative Disorders 1 Immune System Diseases 1 Hemoglobinopathies 1 Hematologic Neoplasms 1

Interventions

fludarabine 1 belinostat 1 Cyclophosphamide 1 Azacitidine 1 Abatacept 1 10-propargyl-10-deazaaminopterin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡